Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 77.68% is 36146% above its 3-year average of -0.22%, near the high end of its 3-year range (-11.93%–77.68%).
18123.20% above its 12-month average of -0.43%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2025 (2025-12-31): -11.93%.
GROSS MARGIN
77.68%
GROSS MARGIN AVG TTM
-0.43%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+18123.20%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
38.44%
median of 682 covered companies
CURRENT VS SECTOR MEDIAN
+102.08%
vs the sector median at left
Basel Medical Group Ltd Ordinary Shares
Market Cap
$5.01M
Gross Margin
77.68%
TTM Avg
-0.43%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.79M
Gross Margin
100.00%
TTM Avg
99.28%
3Y Avg
89.13%
5Y Avg
81.38%
Market Cap
$5.16M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.27M
Gross Margin
48.63%
TTM Avg
44.74%
3Y Avg
40.32%
5Y Avg
43.55%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Basel Medical Group Ltd Ordinary Shares (BMGL) | $5.01M | 77.68% | -0.43% | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Imunon, Inc. (IMNN)vs › | $5.04M | 0.00% | 0.00% | 25.00% | 50.00% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.79M | 100.00% | 99.28% | 89.13% | 81.38% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.16M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | 0.00% | 4.10% | -76.22% | -67.08% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | 48.63% | 44.74% | 40.32% | 43.55% |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | 100.00% | 50.00% | 43.60% | 29.07% |
Gross Margin
77.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | -11.93% |
| 2025-06-30 | 10.64% |
| 2024-12-31 | 0.00% |
| 2024-06-30 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | 0.00% |
